Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer

Immunity

Volumn 39, Issue 4, 2013, Pages 782-795

  Bindea, Gabriela ^a,b   Mlecnik, Bernhard ^a,b   Tosolini, Marie ^a,b   Kirilovsky, Amos ^a,b   Waldner, Maximilian ^a,b,c   Obenauf, Anna C ^d   Angell, Helen ^a,b   Fredriksen, Tessa ^a,b   Lafontaine, Lucie ^a,b   Berger, Anne ^e   Bruneval, Patrick ^f   Fridman, WolfHerman ^a,b   Becker, Christoph ^c   Pagès, Franck ^a,b,f   Speicher, Michael R ^d   Trajanoski, Zlatko ^g   Galon, JérÔme ^a,b,e  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL13 CHEMOKINE; INTERLEUKIN 21;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CANCER IMMUNOLOGY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL TYPE; COLON CANCER; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; B-LYMPHOCYTES; CARCINOMA; CELL MOVEMENT; CHEMOKINE CXCL13; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INTERLEUKINS; LYMPHOCYTE COUNT; MICE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROTEIN STABILITY; SURVIVAL ANALYSIS; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR MICROENVIRONMENT;

EID: 84885724091     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.10.003     Document Type: Article

References (57)

1. Allard E.L., Hardy M.P., Leignadier J., Marquis M., Rooney J., Lehoux D., Labrecque N. Overexpression of IL-21 promotes massive CD8+ memory Tcell accumulation. Eur. J. Immunol. 2007, 37:3069-3077.
2. Altman D.G., Lausen B., Sauerbrei W., Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J.Natl. Cancer Inst. 1994, 86:829-835.
3. Ancona N., Maglietta R., Piepoli A., D'Addabbo A., Cotugno R., Savino M., Liuni S., Carella M., Pesole G., Perri F. On the statistical assessment of classifiers using DNA microarray data. BMC Bioinformatics 2006, 7:387.
4. Angell H., Galon J. From the immune contexture to the Immunoscore: The role of prognostic and predictive immune markers in cancer. Curr. Opin. Immunol. 2013, 25:261-267.
5. Atreya I., Neurath M.F. Immune cells in colorectal cancer: Prognostic relevance and therapeutic strategies. Expert Rev. Anticancer Ther. 2008, 8:561-572.
6. Barrett T., Suzek T.O., Troup D.B., Wilhite S.E., Ngau W.C., Ledoux P., Rudnev D., Lash A.E., Fujibuchi W., Edgar R. NCBI GEO: mining millions of expression profiles-Database and tools. Nucleic Acids Res. 2005, 33(Database issue):D562-D566.
7. Baumjohann D., Preite S., Reboldi A., Ronchi F., Ansel K.M., Lanzavecchia A., Sallusto F. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity 2013, 38:596-605.
8. Benoist C., Germain R.N., Mathis D. A plaidoyer for 'systems immunology'. Immunol. Rev. 2006, 210:229-234.
9. Bindea G., Mlecnik B., Hackl H., Charoentong P., Tosolini M., Kirilovsky A., Fridman W.H., Pagès F., Trajanoski Z., Galon J. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009, 25:1091-1093.
10. Bindea G., Mlecnik B., Fridman W.H., Pagès F., Galon J. Natural immunity to cancer in humans. Curr. Opin. Immunol. 2010, 22:215-222.
11. Bindea G., Galon J., Mlecnik B. CluePedia Cytoscape plugin: pathway insights using integrated experimental and insilico data. Bioinformatics 2013, 29:661-663.
12. Cannons J.L., Lu K.T., Schwartzberg P.L. T follicular helper cell diversity and plasticity. Trends Immunol. 2013, 34:200-207.
13. Chtanova T., Newton R., Liu S.M., Weininger L., Young T.R., Silva D.G., Bertoni F., Rinaldi A., Chappaz S., Sallusto F., et al. Identification of Tcell-restricted genes, and signatures for different Tcell responses, using a comprehensive collection of microarray datasets. J.Immunol. 2005, 175:7837-7847.
14. DeNardo D.G., Andreu P., Coussens L.M. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev. 2010, 29:309-316.
15. Deola S., Panelli M.C., Maric D., Selleri S., Dmitrieva N.I., Voss C.Y., Klein H., Stroncek D., Wang E., Marincola F.M. Helper B cells promote cytotoxic Tcell survival and proliferation independently of antigen presentation through CD27/CD70 interactions. J.Immunol. 2008, 180:1362-1372.
16. Finn O.J. Cancer immunology. N.Engl. J. Med. 2008, 358:2704-2715.
17. Fridman W.H., Pagès F., Sautès-Fridman C., Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat. Rev. Cancer 2012, 12:298-306.
18. Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pagès C., Tosolini M., Camus M., Berger A., Wind P., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006, 313:1960-1964.
19. Galon J., Fridman W.H., Pagès F. The adaptive immunologic microenvironment in colorectal cancer: a novel perspective. Cancer Res. 2007, 67:1883-1886.
20. Galon J., Angell H.K., Bedognetti D., Marincola F.M. The continuum of cancer immunosurveillance: Prognostic, predictive, and mechanistic signatures. Immunity 2013, 39:11-26.
21. Gilchrist M., Thorsson V., Li B., Rust A.G., Korb M., Roach J.C., Kennedy K., Hai T., Bolouri H., Aderem A. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006, 441:173-178.
22. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 1996, 15:361-387.
23. Heagerty P.J., Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics 2005, 61:92-105.
24. Holländer N., Sauerbrei W., Schumacher M. Confidence intervals for the effect of a prognostic factor after selection of an 'optimal' cutpoint. Stat. Med. 2004, 23:1701-1713.
25. Hyrcza M.D., Kovacs C., Loutfy M., Halpenny R., Heisler L., Yang S., Wilkins O., Ostrowski M., Der S.D. Distinct transcriptional profiles in exvivo CD4+ and CD8+ Tcells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ Tcells. J.Virol. 2007, 81:3477-3486.
26. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., Thun M.J. Cancer statistics, 2006. CA Cancer J. Clin. 2006, 56:106-130.
27. Jenh C.H., Cox M.A., Hipkin W., Lu T., Pugliese-Sivo C., Gonsiorek W., Chou C.C., Narula S.K., Zavodny P.J. Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor. Cytokine 2001, 15:113-121.
28. June C.H. Adoptive Tcell therapy for cancer in the clinic. J.Clin. Invest. 2007, 117:1466-1476.
29. June C.H. Principles of adoptive Tcell cancer therapy. J.Clin. Invest. 2007, 117:1204-1212.
30. Kim P.S., Levy D., Lee P.P. Modeling and simulation of the immune system as a self-regulating network. Methods Enzymol. 2009, 467:79-109.
31. King C., Tangye S.G., Mackay C.R. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 2008, 26:741-766.
32. Koebel C.M., Vermi W., Swann J.B., Zerafa N., Rodig S.J., Old L.J., Smyth M.J., Schreiber R.D. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007, 450:903-907.
33. Lund F.E., Randall T.D. Effector and regulatory B cells: Modulators of CD4+ Tcell immunity. Nat. Rev. Immunol. 2010, 10:236-247.
34. Lüthje K., Kallies A., Shimohakamada Y., Belz G.T., Light A., Tarlinton D.M., Nutt S.L. The development and fate of follicular helper Tcells defined by an IL-21 reporter mouse. Nat. Immunol. 2012, 13:491-498.
35. Mlecnik B., Sanchez-Cabo F., Charoentong P., Bindea G., Pagès F., Berger A., Galon J., Trajanoski Z. Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction. BMC Genomics 2010, 11(Suppl 1):S7.
36. Mlecnik B., Tosolini M., Charoentong P., Kirilovsky A., Bindea G., Berger A., Camus M., Gillard M., Bruneval P., Fridman W.H., et al. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology 2010, 138:1429-1440.
37. Mlecnik B., Tosolini M., Kirilovsky A., Berger A., Bindea G., Meatchi T., Bruneval P., Trajanoski Z., Fridman W.H., Pagès F., Galon J. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J. Clin. Oncol. 2011, 29:610-618.
38. Nakayamada S., Kanno Y., Takahashi H., Jankovic D., Lu K.T., Johnson T.A., Sun H.W., Vahedi G., Hakim O., Handon R., et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 2011, 35:919-931.
39. Nurieva R.I., Chung Y., Hwang D., Yang X.O., Kang H.S., Ma L., Wang Y.H., Watowich S.S., Jetten A.M., Tian Q., Dong C. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008, 29:138-149.
40. Pagès F., Berger A., Camus M., Sanchez-Cabo F., Costes A., Molidor R., Mlecnik B., Kirilovsky A., Nilsson M., Damotte D., et al. Effector memory Tcells, early metastasis, and survival in colorectal cancer. N.Engl. J. Med. 2005, 353:2654-2666.
41. Pagès F., Kirilovsky A., Mlecnik B., Asslaber M., Tosolini M., Bindea G., Lagorce C., Wind P., Marliot F., Bruneval P., et al. In situ cytotoxic and memory Tcells predict outcome in patients with early-stage colorectal cancer. J.Clin. Oncol. 2009, 27:5944-5951.
42. Pape K.A., Taylor J.J., Maul R.W., Gearhart P.J., Jenkins M.K. Different B cell populations mediate early and late memory during an endogenous immune response. Science 2011, 331:1203-1207.
43. Parkinson H., Kapushesky M., Shojatalab M., Abeygunawardena N., Coulson R., Farne A., Holloway E., Kolesnykov N., Lilja P., Lukk M., et al. ArrayExpress-A public database of microarray experiments and gene expression profiles. Nucleic Acids Res. 2007, 35(Database issue):D747-D750.
44. Provenzani A., Fronza R., Loreni F., Pascale A., Amadio M., Quattrone A. Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. Carcinogenesis 2006, 27:1323-1333.
45. Schreiber R.D., Old L.J., Smyth M.J. Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science 2011, 331:1565-1570.
46. Shankaran V., Ikeda H., Bruce A.T., White J.M., Swanson P.E., Old L.J., Schreiber R.D. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001, 410:1107-1111.
47. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13:2498-2504.
48. Smyth M.J., Dunn G.P., Schreiber R.D. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv. Immunol. 2006, 90:1-50.
49. Sturn A., Quackenbush J., Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 2002, 18:207-208.
50. Sutherland A.P., Joller N., Michaud M., Liu S.M., Kuchroo V.K., Grusby M.J. IL-21 promotes CD8+ CTL activity via the transcription factor T-bet. J.Immunol. 2013, 190:3977-3984.
51. Tangye S.G., Ma C.S., Brink R., Deenick E.K. The good, the bad and the ugly - TFH cells in human health and disease. Nat. Rev. Immunol. 2013, 13:412-426.
52. Tegnér J., Nilsson R., Bajic V.B., Björkegren J., Ravasi T. Systems biology of innate immunity. Cell. Immunol. 2006, 244:105-109.
53. Tsafrir D., Bacolod M., Selvanayagam Z., Tsafrir I., Shia J., Zeng Z., Liu H., Krier C., Stengel R.F., Barany F., et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res. 2006, 66:2129-2137.
54. Wang E., Panelli M.C., Monsurró V., Marincola F.M. A global approach to tumor immunology. Cell. Mol. Immunol. 2004, 1:256-265.
55. Wang E., Worschech A., Marincola F.M. The immunologic constant of rejection. Trends Immunol. 2008, 29:256-262.
56. Weitz J., Koch M., Debus J., Höhler T., Galle P.R., Büchler M.W. Colorectal cancer. Lancet 2005, 365:153-165.
57. Wendt K., Wilk E., Buyny S., Buer J., Schmidt R.E., Jacobs R. Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells. J.Leukoc. Biol. 2006, 80:1529-1541.